Systemic Barriers to Genomic Testing in Cancer Care: A Study on Disparities in Access to Targeted Therapies
Original framing: “STAT+: Many cancer patients don’t get genomic tests to guide treatment, study finds” — STAT News
The core of the story rests on scientific evidence: data showing that genomic testing improves survival, the methodological rigor of the study, and the clinical rationale for targeted therapies.
The disparity in genomic testing reflects entrenched historical inequities amplified by a lack of cross‑cultural insight and Indigenous inclusion, even as robust scientific evidence underscores its life‑saving potential.
Future modelling shows that removing financial and logistical barriers could dramatically improve outcomes, but only if policies are coupled with standardized guidelines, provider education, and community‑driven navigation. By weaving together historical context, scientific rigor, and forward‑looking systemic solutions, a more equitable cancer care landscape can emerge.